Overview
Phytobezoars are concretions of vegetable fibers that form within the gastrointestinal tract, typically in the stomach, due to impaired digestion and mechanical obstruction. They are most commonly associated with the consumption of high-fiber foods like persimmons (especially the seeds), but can also result from other plant materials. Clinically significant due to symptoms such as nausea, vomiting, abdominal pain, and gastrointestinal obstruction, phytobezoars disproportionately affect individuals with underlying motility disorders, such as diabetes mellitus with gastroparesis, or those who have undergone gastric surgery. Early recognition and management are crucial to prevent complications like bezoar-induced bowel obstruction, which can be life-threatening. This matters in day-to-day practice because timely intervention can avert severe complications and improve patient outcomes. 12Pathophysiology
Phytobezoars form when plant fibers, particularly those resistant to normal digestive processes, accumulate and aggregate within the stomach or intestines. The impaired mechanical breakdown and delayed gastric emptying contribute significantly to their formation. In individuals with reduced gastric motility, such as those with diabetes-related gastroparesis or post-surgical states, the retention time of ingested plant material increases, facilitating aggregation into bezoars. Molecularly, the high fiber content and complex structures of certain plant materials resist enzymatic degradation, leading to physical obstruction and potential inflammatory responses within the gastrointestinal tract. This aggregation process can exacerbate existing motility issues, creating a vicious cycle that further impedes normal digestive function. 12Epidemiology
The incidence of phytobezoars is relatively low but notable among specific populations. They are more prevalent in regions where certain high-fiber foods, particularly persimmons, are commonly consumed. Age and sex distribution show no significant predilection, but individuals with predisposing conditions such as diabetes mellitus, previous gastric surgeries (like vagotomy or gastrectomy), and those with idiopathic or secondary gastroparesis are at higher risk. Trends suggest an increasing awareness and reporting, possibly due to better diagnostic imaging techniques and heightened clinical vigilance. However, precise global incidence and prevalence figures remain limited, highlighting the need for more comprehensive epidemiological studies. 12Clinical Presentation
Typical symptoms of phytobezoars include recurrent nausea, vomiting (often with undigested food particles), abdominal pain, early satiety, and in severe cases, gastrointestinal obstruction. Red-flag features include intractable vomiting, severe abdominal distension, signs of dehydration, and in extreme cases, shock. Patients may also report a history of consuming high-fiber foods, particularly persimmon seeds. Atypical presentations can mimic other gastrointestinal disorders, complicating early diagnosis. Prompt recognition of these symptoms is essential to differentiate phytobezoars from other causes of gastrointestinal obstruction or functional dyspepsia. 12Diagnosis
The diagnostic approach for phytobezoars involves a combination of clinical history, physical examination, and imaging studies. Key diagnostic criteria and tests include:Differential Diagnosis:
Management
Initial Management
Interventional Approaches
Contraindications:
Complications
Prognosis & Follow-up
The prognosis for phytobezoar patients is generally good with prompt and appropriate management. Recurrence is possible, especially in those with underlying motility disorders. Key prognostic indicators include the presence of predisposing conditions and adherence to dietary modifications. Recommended follow-up intervals include:Special Populations
Key Recommendations
References
1 Hashmi AR, Sekar M, Wong LS, Prashantha Kumar BR, Mat Rani NNI, Kumarasamy V. Bixin Beyond Colour: Expanding Therapeutic Horizons Through the Integration of Pharmacological Potential with Modern Drug Design and Delivery Strategies. Drug design, development and therapy 2026. link 2 Sepp J, Koshovyi O, Jakštas V, Žvikas V, Botsula I, Kireyev I et al.. Phytochemical, Pharmacological, and Molecular Docking Study of Dry Extracts of . Biomolecules 2024. link 3 Liu Q, Wen Y, Zhang J, Qiu W, Gao M, Dong Y et al.. Polystyrene microplastics decrease dibutyl phthalate uptake and metabolism in pumpkins. Ecotoxicology and environmental safety 2026. link 4 Shoman N, Solomonova E, Akimov A. Assessing the ecological risks of ZnO and CuO nanoparticles to black sea picophytoplankton. Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 2026. link 5 Patel SA, Currie F, Thakker N, Goodacre R. Spatial metabolic fingerprinting using FT-IR spectroscopy: investigating abiotic stresses on Micrasterias hardyi. The Analyst 2008. link 6 Cordell GA, Lyon RL, Fong HH, Benoit PS, Farnsworth NR. Biological and phytochemical investigations of Dianthus barbatus cv. "China Doll" (Caryophyllaceae). Lloydia 1977. link